Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
The Cancer Letter's weekly podcast of interviews, discussions, and more to dig deep into the issues that shape oncology.
New episodes every Wednesday.
SUBSCRIBE ON
Spotify Apple Podcast YouTube
Spotify Apple Podcast YouTube
on air
Trump’s tariffs on generic drugs are “another wrinkle in an already unstable system”
Podcast

Trump’s tariffs on generic drugs are “another wrinkle in an already unstable system”

August 26, 2026
Raja Flores says oncology is loose with staging jargon, and now “it’s confusing my patients.”
Podcast

Raja Flores says oncology is loose with staging jargon, and now “it’s confusing my patients.”

August 19, 2026
What happened at FDA? Replimune approval raises questions
Podcast

What happened at FDA? Replimune approval raises questions

August 12, 2026
The Directors: New directors Herbst and Gius chart a future built on AI, collaboration, and rural access
PodcastThe Directors

The Directors: New directors Herbst and Gius chart a future built on AI, collaboration, and rural access

August 07, 2026
Vol.52 No.31
By Claire Marie Porter and Paul Goldberg
Pour a Scotch, we’re talking clinical trials and prediction markets
Podcast

Pour a Scotch, we’re talking clinical trials and prediction markets

August 05, 2026
Vol.52 No.31
Hegseth offers soldiers testosterone and FDA loosens safety warnings. Is the science there?
Podcast

Hegseth offers soldiers testosterone and FDA loosens safety warnings. Is the science there?

July 29, 2026
Vol.52 No.29
How will FDA regulate psychedelics?
Podcast

How will FDA regulate psychedelics?

July 22, 2026
Vol.52 No.28
The Directors: Two leaders in data science have a warp speed vision for AI, with cancer clinical trials leading the way
PodcastThe Directors

The Directors: Two leaders in data science have a warp speed vision for AI, with cancer clinical trials leading the way
Knudsen and Thoelke: “It’s actually solving for bottlenecks and challenges that we’ve been unable to overcome for so long”

July 17, 2026
Vol.52 No.28
By Paul Goldberg and Claire Marie Porter
Did peer review fail? Nature Medicine’s chronotherapy paper retraction raises questions
Podcast

Did peer review fail? Nature Medicine’s chronotherapy paper retraction raises questions

July 15, 2026
Vol.52 No.27
A new diagnostic lens—and a lasting scientific legacy
Podcast

A new diagnostic lens—and a lasting scientific legacy

July 08, 2026
Vol.52 No.26

Posts navigation

123…11Next

Trending Stories

  • From “default dead” to living the future of cancer care
    As founding CEO of GitLab, I went “founder mode” on my osteosarcoma
  • Trump’s tariffs on generic drugs are “another wrinkle in an already unstable system”
  • A new AI tool enables speedy use of ASCO guidelines, eliminating typical errors
  • NCAB asks for help from administration as NCI deals with deluge of grant applications
  • Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
  • Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account